Final program
OBJECTIVE
Following the success of our Courses in 2017, 2018, and 2020, the
objective of the Fourth International Melanoma Course in 2022 will
include a new criteria-based approach: “Avoiding errors in diagnosis via true cases”, as well as an update of all cutting-edge knowledge on difficult melanocytes lesions relevant to practicing pathologists and clinicians.
This 2022 venue will make use of the expertise of the SIRIC (Integrated Cancer Research Site at Institut Curie), updated WHO 4th Edition Classification of Melanocytic Tumours, the International Melanoma Pathology Study Group, and the latest information from the MPATH Melanoma Pathology studies.
8:15
Introduction
Raymond Barnhill
8:20
Criteria for melanocytic lesions: an introduction.
Raymond Barnhill
8:50
Immunohistochemistry for pathologists.
Klaus Busam
9:20
ImmuMolecular diagnostics for pathologists.nohistochemistry for pathologists.
Boris Bastian
10:30
MPath classification.
Raymond Barnhill
10:50
AJCC 8th edition guidelines.
Richard Scolyer
11:10
Prognostic factors in melanoma.
Lori Lowe
11:30
Treatment recommendations for melanocytic lesions.
David Elder
13:00
Classification of melanoma for pathologists.
Boris Bastian
13:30
Lentigo maligna melanoma.
Klaus Busam
13:50
Ocular melanocytic lesions: an update clinical aspects
– Conjunctival lesions. Nathalie Cassoux
– Uveal melanoma, nevus. Alexandre Matet
14:10
Conjunctival melanocytic lesions: pathological aspects.
Raymond Barnhill
14:25
Uveal melanoma: pathological aspects.
Raymond Barnhill
14:40
Angiotropic extravascular migratory metastases.
Claire Lugassy
15:30
Case presentations
(10 cases, 10 min/case with discussion)
8:10
Acquired melanocytic nevi.
David Elder
8:40
Spitz nevus, atypical Spitz tumor, Spitz melanoma.
Raymond Barnhill
9:10
Blue nevus and melanoma arising
in blue nevus
Arnaud de la Fouchardière
9:40
Site-specific nevi (including scalp, breast and milk-line, flexural, perianal).
David Elder
10:30
Combined melanocytic nevi: BAP1, deep penetrating, pigmented epithelioid melanocytoma, etc.
Arnaud de la Fouchardière
11:00
Pediatric melanocytic lesions.
Raymond Barnhill
11:20
Acral melanocytic nevi and melanoma.
Richard Scolyer
11:50
Metastatic melanoma and rare variants of melanoma.
Lori Lowe
13:10
Nevoid melanoma.
Klaus Busam
13:30
Desmoplastic nevi and desmoplastic melanoma.
Klaus Busam
13:50
Oral and genital melanocytic lesions.
Richard Scolyer
14:10
Sentinel lymph nodes: what is important?
Lori Lowe
14:30
Predictive biomarkers for targeted and checkpoint inhibitor therapies.
Richard Scolyer
15:30
Case presentations continued
(10 cases, 10 min/case with discussion)
